PLX4032
Information
- Drug Name
- PLX4032
- Description
- Entry(CIViC)
CIViC
[No Data.]
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Treatment of metastatic melanoma with PLX4032 in p... | BRAF | BRAF V600E | Sensitivity | true | MMMP | detail |
| PLX4032 is a BRAF inhibitor with high selectivity ... | BRAF | BRAF V600E | Sensitivity | true | MMMP | detail |
| PLX4032 is a BRAF inhibitor with high selectivity ... | BRAF | BRAF V600E | Sensitivity | true | MMMP | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00405587 | Completed | Phase 1 | Safety Study of PLX4032 in Patients With Solid Tumors | November 2006 | February 2016 |